Prevalence of atrial fibrillation and antithrombotic therapy in a group of primary health care clinics in the North of Portugal

Authors

  • Diana Oliveira Médicas internas de Medicina Geral e Familiar, UCSP Foz do Douro – ACeS Porto Ocidental
  • Joana Coelho Médicos internos de Medicina Geral e Familiar, USF Porto Douro – ACeS Porto Ocidental
  • Manuel Magalhães Médicos internos de Medicina Geral e Familiar, USF Porto Douro – ACeS Porto Ocidental
  • Mariana Oliveira Médicas internas de Medicina Geral e Familiar, UCSP Foz do Douro – ACeS Porto Ocidental

DOI:

https://doi.org/10.32385/rpmgf.v30i5.11385

Keywords:

Atrial Fibrillation, Prevalence, CHA2DS2VASc Score, Anticoagulation

Abstract

Objectives: To determine the prevalence of atrial fibrillation among patients in primary health care clinics in West Porto in May 2013, to assess the distribution of CHA2DS2VASc risk factors for thromboembolism, to study antithrombotic therapy and the sites where anticoagulation therapy is managed. Type of Study: Cross-sectional study. Setting: Primary Health Care Centres of West Porto. Population: Patients registered in the health units of West Porto. Methods: Data were collected from the electronic medical records using SIARS, MIM@UF and SAM software. The chi-squared statistic was used for comparison of proportions, with statistical significance set at the p < 0.05 level. Results: The authors identified 1628 people with atrial fibrillation. Of these 58% were female. They ranged in age from 29 to 104 years with a mean age of 76 ± 11 years. The prevalence of atrial fibrillation was 0.98%, with a prevalence of 1.77% in patients over 39 years. The CHA2DS2VASc score was greater than zero in 95% of patients, excluding cases where female gender was the only risk factor. The main risk factors were arterial hypertension (75%), age greater than 74 years (62%) and female gender. Anticoagulation therapy was prescribed to 68% of patients with 88% receiving vitamin K antagonists. Follow-up of anticoagulation was performed in clinical laboratories in 74% of cases. Conclusions: The prevalence of atrial fibrillation in this population was greater than that reported in a national study in 2006 (0.5%). However the prevalence in patients over 39 years of age was less than that found in a study conducted in 2010, using electrocardiographic diagnosis (2.5%). Identification of patients with atrial fibrillation is an important task in primary health care.

Downloads

Download data is not yet available.

Downloads

Published

2014-09-01

Issue

Vol. 30 No. 5 (2014): Revista Portuguesa de Medicina Geral e Familiar

Section

Original Research

License

The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.

The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.

 

How to Cite

Prevalence of atrial fibrillation and antithrombotic therapy in a group of primary health care clinics in the North of Portugal. (2014). Portuguese Journal of Family Medicine and General Practice, 30(5), 292-8. https://doi.org/10.32385/rpmgf.v30i5.11385